Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Hunzelmann

Showing results (61-70 of 144) with videos related to

Pageof 15
Sort By:
Dermatology Research and Practice|July 31, 2010
Targeted immunotherapy with rituximab leads to a transient alteration of the IgG autoantibody profile in pemphigus vulgarisRalf Müller, Nicolas Hunzelmann, Vera Baur, et al.
Experimental Dermatology|June 29, 2011
Elevated MMP-7 levels in patients with systemic sclerosis: correlation with pulmonary involvementPia Moinzadeh, Thomas Krieg, Martin Hellmich, et al.
Acta Dermato-Venereologica|March 7, 2018
Localized Scleroderma of the Head and Face Area: A Retrospective Cross-sectional Study of 96 Patients from 5 German Tertiary Referral CentresAlexander Kreuter, Georg Mitrakos, Silke C Hofmann, et al.
International Journal of Cardiology|August 21, 2016
N-terminal pro-brain natriuretic peptide is a strong predictor of mortality in systemic sclerosisYannick Allanore, Andras Komocsi, Serena Vettori, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|September 22, 2006
Tissue transglutaminase ELISA positivity in autoimmune disease independent of gluten-sensitive diseaseMiklós Sárdy, Márta Csikós, Christof Geisen, et al.
Seminars in Arthritis and Rheumatism|May 1, 2018
Practical suggestions on intravenous iloprost in Raynaud's phenomenon and digital ulcer secondary to systemic sclerosis: Systematic literature review and expert consensusFrancesca Ingegnoli, Tommaso Schioppo, Yannick Allanore, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|January 29, 2016
German guidelines for the diagnosis and therapy of localized sclerodermaAlexander Kreuter, Thomas Krieg, Margitta Worm, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 1, 2024
S2k guideline: Diagnosis and therapy of localized sclerodermaAlexander Kreuter, Pia Moinzadeh, Maria Kinberger, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|May 15, 2012
Efficacy and safety of rituximab in pemphigus: experience of the German Registry of Autoimmune DiseasesMichael Kasperkiewicz, Rüdiger Eming, Melika Behzad, et al.
Journal of Scleroderma and Related Disorders|April 6, 2022
Prediction of organ involvement and survival in systemic sclerosis patients in the first 5 years from diagnosisWieneke Mt van den Hombergh, Hanneke Ka Knaapen-Hans, Frank Hj van den Hoogen, et al.
Pageof 15

Showing results (61-70 of 144) with videos related to

Sort By:
Pageof 15
Dermatology Research and Practice|July 31, 2010
Targeted immunotherapy with rituximab leads to a transient alteration of the IgG autoantibody profile in pemphigus vulgarisRalf Müller, Nicolas Hunzelmann, Vera Baur, et al.
Experimental Dermatology|June 29, 2011
Elevated MMP-7 levels in patients with systemic sclerosis: correlation with pulmonary involvementPia Moinzadeh, Thomas Krieg, Martin Hellmich, et al.
Acta Dermato-Venereologica|March 7, 2018
Localized Scleroderma of the Head and Face Area: A Retrospective Cross-sectional Study of 96 Patients from 5 German Tertiary Referral CentresAlexander Kreuter, Georg Mitrakos, Silke C Hofmann, et al.
International Journal of Cardiology|August 21, 2016
N-terminal pro-brain natriuretic peptide is a strong predictor of mortality in systemic sclerosisYannick Allanore, Andras Komocsi, Serena Vettori, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|September 22, 2006
Tissue transglutaminase ELISA positivity in autoimmune disease independent of gluten-sensitive diseaseMiklós Sárdy, Márta Csikós, Christof Geisen, et al.
Seminars in Arthritis and Rheumatism|May 1, 2018
Practical suggestions on intravenous iloprost in Raynaud's phenomenon and digital ulcer secondary to systemic sclerosis: Systematic literature review and expert consensusFrancesca Ingegnoli, Tommaso Schioppo, Yannick Allanore, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|January 29, 2016
German guidelines for the diagnosis and therapy of localized sclerodermaAlexander Kreuter, Thomas Krieg, Margitta Worm, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 1, 2024
S2k guideline: Diagnosis and therapy of localized sclerodermaAlexander Kreuter, Pia Moinzadeh, Maria Kinberger, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|May 15, 2012
Efficacy and safety of rituximab in pemphigus: experience of the German Registry of Autoimmune DiseasesMichael Kasperkiewicz, Rüdiger Eming, Melika Behzad, et al.
Journal of Scleroderma and Related Disorders|April 6, 2022
Prediction of organ involvement and survival in systemic sclerosis patients in the first 5 years from diagnosisWieneke Mt van den Hombergh, Hanneke Ka Knaapen-Hans, Frank Hj van den Hoogen, et al.
Pageof 15